Nirmatrelvir Plus Ritonavir: First Approval (vol 82, pg 585, 2022)

被引：0

|

作者：

Lamb, Yvette N. ^{[1
]}

机构：

[1] Mairangi Bay, Springer Nat, Private Bag 65901, Auckland 0754, New Zealand

来源：

DRUGS | 2022年 / 82卷 / 09期

关键词：

D O I：

10.1007/s40265-022-01737-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：1025 / 1025

页数：1

相关论文

共 50 条

[1] Nirmatrelvir Plus Ritonavir: First Approval
Yvette N. Lamb
Drugs, 2022, 82 : 585 - 591
[2] Nirmatrelvir Plus Ritonavir: First Approval
Lamb, Yvette N.
DRUGS, 2022, 82 (05) : 585 - 591
[3] Correction to: Nirmatrelvir Plus Ritonavir: First Approval
Yvette N. Lamb
Drugs, 2022, 82 (9) : 1025 - 1025
[4] Spesolimab: First Approval (vol 82, pg 1681, 2022)
Blair, Hannah A.
DRUGS, 2023, 83 (01) : 103 - 103
[5] Efgartigimod: First Approval (vol 82, pg 341, 2022)
Heo, Young-A
DRUGS, 2022, 82 (05) : 611 - 611
[6] Daridorexant: First Approval (vol 82, pg 601, 2022)
Markham, Anthony
DRUGS, 2022, 82 (07) : 841 - 841
[7] Lenacapavir: First Approval (vol 82, pg 1499, 2022)
Paik, Julia
DRUGS, 2023, 83 (11) : 1061 - 1061
[8] Mavacamten: First Approval (vol 82, pg 1127, 2022)
Keam, Susan J.
DRUGS, 2022, 82 (11) : 1235 - 1235
[9] Valemetostat Tosilate: First Approval (vol 82, pg 1621, 2022)
Keam, Susan J.
DRUGS, 2022, 82 (17) : 1689 - 1689
[10] Tapinarof Cream 1%: First Approval (vol 82, pg 1221, 2022)
Keam, Susan J.
DRUGS, 2022, 82 (13) : 1433 - 1433

← 1 2 3 4 5 →